MA SONGJIANG (President) sold 0.1% of their position (4K shares) of GYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $48.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/17/2025ACC: 0001140361-25-009017
DirectorOfficer· President
Since Oct 2023
-4K
Net shares
Net seller
$48.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−2K
Price / share
$11.80
Trade value
$23.60K
% of position
0.1%
3/13/2025
2.84M→2.83M
Common Stock
Indirect
Shares
−2K
Price / share
$12.31
Trade value
$24.62K
% of position
0.1%
3/14/2025
2.83M→2.83M
Total
Net shares
−4K
Net value
-$48.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/13/2025 | S · Sale | −2K | $11.80 | $23.60K | 0.1% | 2.84M | 2.83M |
| Common Stock Indirect | 3/14/2025 | S · Sale | −2K | $12.31 | $24.62K | 0.1% | 2.83M | 2.83M |
| Total | −4K | -$48.22K | ||||||
Derivative Transactions0
No derivative transactions reported